ZL-1218
- Generic Name
- ZL-1218
A Phase 1 Study of ZL-1218 in Subjects With Advanced Solid Tumors
- First Posted Date
- 2023-05-16
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Zai Lab (Hong Kong), Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05859464
- Locations
- 🇺🇸
Zai Lab Site 2005, Irvine, California, United States
🇺🇸Zai Lab Site 2007, Detroit, Michigan, United States
🇺🇸Zai Lab Site 2001, Hackensack, New Jersey, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath